Form 8-K - Current report:
SEC Accession No. 0001193125-24-240019
Filing Date
2024-10-21
Accepted
2024-10-21 07:00:32
Documents
14
Period of Report
2024-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d854911d8k.htm   iXBRL 8-K 27010
2 EX-99.1 d854911dex991.htm EX-99.1 12866
  Complete submission text file 0001193125-24-240019.txt   164037

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20241021.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20241021_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20241021_pre.xml EX-101.PRE 10807
16 EXTRACTED XBRL INSTANCE DOCUMENT d854911d8k_htm.xml XML 3489
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 241381951
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)